![CG Oncology Inc](/common/images/company/N_CGON.png)
CG Oncology is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. We see a world where urologic cancer patients can benefit from our innovative immunotherapies to live ... CG Oncology is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. We see a world where urologic cancer patients can benefit from our innovative immunotherapies to live with dignity and have an enhanced quality of life. Show more
IRVINE, Calif., Dec. 16, 2024 (GLOBE NEWSWIRE) -- CG Oncology, Inc. (Nasdaq: CGON), a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone...
IRVINE, Calif., Dec. 12, 2024 (GLOBE NEWSWIRE) -- CG Oncology, Inc. (Nasdaq: CGON), a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone...
IRVINE, Calif., Dec. 11, 2024 (GLOBE NEWSWIRE) -- CG Oncology, Inc. (Nasdaq: CGON), a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone...
SCHAUMBURG, Ill. and IRVINE, Calif., Dec. 06, 2024 (GLOBE NEWSWIRE) -- The Society of Urologic Oncology Clinical Trials Consortium (SUO-CTC), a national alliance of leading academic and...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -1.27 | -4.29925524712 | 29.54 | 30.59 | 28.32 | 416741 | 29.84454144 | CS |
4 | -1.39 | -4.68644639245 | 29.66 | 31.16 | 27.7 | 588585 | 29.74157001 | CS |
12 | -4.78 | -14.462934947 | 33.05 | 36.73 | 27 | 732209 | 30.448639 | CS |
26 | -5.56 | -16.4351167603 | 33.83 | 40.47 | 27 | 676201 | 33.89451504 | CS |
52 | -13.3 | -31.9942266057 | 41.57 | 50.23 | 25.77 | 651319 | 34.75221871 | CS |
156 | -0.73 | -2.51724137931 | 29 | 50.23 | 25.77 | 674210 | 34.95192024 | CS |
260 | -0.73 | -2.51724137931 | 29 | 50.23 | 25.77 | 674210 | 34.95192024 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales